Adenosquamous cancer of the pancreas : A multicenter retrospective study
Copyright © 2021. Publicado por Elsevier España, S.L.U..
INTRODUCTION: Adenosquamous cancer of the pancreas (ASCP) is an aggressive, infrequent subtype of pancreatic cancer that combines a glandular and squamous component and is associated with poor survival.
METHODS: Multicenter retrospective observational study carried out at three Spanish hospitals. The study period was: January 2010-August 2020. A descriptive analysis of the data was performed, as well as an analysis of global and disease-free survival using the Kaplan-Meier statistic.
RESULTS: Of a total of 668 pancreatic cancers treated surgically, twelve were ASCP (1.8%). Patient mean age was 69.2±7.4 years. Male/female ratio was 1:1. The main symptom was jaundice (seven patients). Correct preoperative diagnosis was obtained in only two patients. Nine pancreatoduodenectomies and three distal pancreatosplenectomies were performed. 25% had major complications. Mean tumor size was 48.6±19.4mm. Nine patients received adjuvant chemotherapy. Median survival time was 5.9 months, and median disease-free survival was 4.6 months. 90% of patients presented recurrence. Ten of the twelve patients in the study (83.3%) died, with disease progression being the cause in eight. Of the two surviving patients, one is disease-free and the other has liver metastases.
CONCLUSION: ASCP is a very rare pancreatic tumor with aggressive behavior. It is rarely diagnosed preoperatively. The best treatment, if feasible, is surgery followed by the standard chemotherapy regimens for pancreatic adenocarcinoma.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:45 |
---|---|
Enthalten in: |
Gastroenterologia y hepatologia - 45(2022), 7 vom: 01. Aug., Seite 543-551 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ramia-Angel, José Manuel [VerfasserIn] |
---|
Links: |
---|
Themen: |
Adenoescamoso |
---|
Anmerkungen: |
Date Completed 19.07.2022 Date Revised 26.07.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.gastrohep.2021.12.006 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM334880327 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM334880327 | ||
003 | DE-627 | ||
005 | 20231225224639.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.gastrohep.2021.12.006 |2 doi | |
028 | 5 | 2 | |a pubmed24n1116.xml |
035 | |a (DE-627)NLM334880327 | ||
035 | |a (NLM)34952130 | ||
035 | |a (PII)S0210-5705(21)00330-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ramia-Angel, José Manuel |e verfasserin |4 aut | |
245 | 1 | 0 | |a Adenosquamous cancer of the pancreas |b A multicenter retrospective study |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 19.07.2022 | ||
500 | |a Date Revised 26.07.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2021. Publicado por Elsevier España, S.L.U. | ||
520 | |a INTRODUCTION: Adenosquamous cancer of the pancreas (ASCP) is an aggressive, infrequent subtype of pancreatic cancer that combines a glandular and squamous component and is associated with poor survival | ||
520 | |a METHODS: Multicenter retrospective observational study carried out at three Spanish hospitals. The study period was: January 2010-August 2020. A descriptive analysis of the data was performed, as well as an analysis of global and disease-free survival using the Kaplan-Meier statistic | ||
520 | |a RESULTS: Of a total of 668 pancreatic cancers treated surgically, twelve were ASCP (1.8%). Patient mean age was 69.2±7.4 years. Male/female ratio was 1:1. The main symptom was jaundice (seven patients). Correct preoperative diagnosis was obtained in only two patients. Nine pancreatoduodenectomies and three distal pancreatosplenectomies were performed. 25% had major complications. Mean tumor size was 48.6±19.4mm. Nine patients received adjuvant chemotherapy. Median survival time was 5.9 months, and median disease-free survival was 4.6 months. 90% of patients presented recurrence. Ten of the twelve patients in the study (83.3%) died, with disease progression being the cause in eight. Of the two surviving patients, one is disease-free and the other has liver metastases | ||
520 | |a CONCLUSION: ASCP is a very rare pancreatic tumor with aggressive behavior. It is rarely diagnosed preoperatively. The best treatment, if feasible, is surgery followed by the standard chemotherapy regimens for pancreatic adenocarcinoma | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Multicenter Study | |
650 | 4 | |a Observational Study | |
650 | 4 | |a Adenoescamoso | |
650 | 4 | |a Adenosquamous | |
650 | 4 | |a Cancer | |
650 | 4 | |a Cirugía | |
650 | 4 | |a Cáncer | |
650 | 4 | |a Pancreas | |
650 | 4 | |a Páncreas | |
650 | 4 | |a Surgery | |
650 | 7 | |a Adjuvants, Pharmaceutic |2 NLM | |
700 | 1 | |a Jaén-Torrejimeno, Isabel |e verfasserin |4 aut | |
700 | 1 | |a Serrablo-Requejo, Alejandro |e verfasserin |4 aut | |
700 | 1 | |a Rodríguez-Laiz, Gonzalo P |e verfasserin |4 aut | |
700 | 1 | |a López-Guerra, Diego |e verfasserin |4 aut | |
700 | 1 | |a Abadía-Forcén, Teresa |e verfasserin |4 aut | |
700 | 1 | |a Alenda, Cristina |e verfasserin |4 aut | |
700 | 1 | |a Serradilla-Martín, Mario |e verfasserin |4 aut | |
700 | 1 | |a Blanco-Fernández, Gerardo |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Gastroenterologia y hepatologia |d 1993 |g 45(2022), 7 vom: 01. Aug., Seite 543-551 |w (DE-627)NLM075187280 |x 0210-5705 |7 nnns |
773 | 1 | 8 | |g volume:45 |g year:2022 |g number:7 |g day:01 |g month:08 |g pages:543-551 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.gastrohep.2021.12.006 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 45 |j 2022 |e 7 |b 01 |c 08 |h 543-551 |